Products for Research Use Only
RegisterLogin

AKT-IN-27

CAT: 0931-T207441-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T207441-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Target
Apoptosis, Akt
Related Pathways
Cytoskeletal Signaling, PI3K/Akt/mTOR signaling, Apoptosis
Bioactivity
AKT-IN-27 (4a) is a potential anticancer drug that functions by selectively targeting Akt-driven signaling pathways. It induces apoptosis by activating caspase-3, causing G2/M phase cell cycle arrest, and disrupting mitochondrial membrane potential. AKT-IN-27 (4a) is applicable in research on triple-negative breast cancer (TNBC) .
Smiles
O=C(C1=C2SC(NC3=CC=CC=C3)=C1C(OCC)=O)C4=CC=CC=C4C2=O
Molecular Formula
C21H15NO4S
Molecular Weight
377.41
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
T210579-01AKT-IN-28
T63039-01AKT-IN-13
T62842-01AKT-IN-8
T61680-01AKT-IN-5
T85615-01AKT-IN-22
T209522-01AKT-IN-17
T209032-01AKT-IN-21
T62771-01AKT-IN-9
T36310-01AKT-IN-6
T4489-01AKT-IN-1

Alternative Products

CatalogName
HY-172900AKT-IN-27
519967-01Akt
SF2784-10mMAKT inhibitor VIII (Akt inhibitor)
YP-W21449-01Mouse AKT (AKT) ELISA Kit
YP-W80334-01Porcine AKT (AKT) ELISA Kit
QY-E11913Rat phospho-AKT (p-AKT)
YP-W10057-01Human AKT (AKT) ELISA Kit
YP-W200333-01Bovine AKT (AKT) ELISA Kit
YP-W72352-01Rabbit AKT (AKT) ELISA Kit
YP-W30042-01Rat AKT (AKT) ELISA Kit

Popular Products